THZ-531

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP28996CAS No. ：1702809-17-3Purity：98%

Size	Price	Stock	Quotation Inquiry
20.00 mg	Get quote	In-stock	Quotation Inquiry
100.00 mg	Get quote	In-stock	Quotation Inquiry

Get Quotation Now

Tel: 0086-17754423994 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	1702809-17-3	Cat. No.	BCP28996
Name	THZ-531
Synonyms	THZ531; THZ 531;
SMILES	O=C(NC1=CC=C(C(N2C[C@H](NC3=NC=C(Cl)C(C4=CNC5=C4C=CC=C5)=N3)CCC2)=O)C=C1)/C=C/CN(C)C
Chemical Name
Formula	C30H32ClN7O2	M. Wt	558.08
Purity	98%	Storage	Store at 4-8°C
Description	THZ531 is a covalent CDK12 and CDK13 covalent inhibitor. Cyclin-dependent kinases 12 and 13 (CDK12 and CDK13) play critical roles in the regulation of gene transcription. THZ531 irreversibly targets a cysteine located outside the kinase domain. THZ531 causes a loss of gene expression with concurrent loss of elongating and hyperphosphorylated RNA polymerase II. THZ531 substantially decreases the expression of DNA damage response genes and key super-enhancer-associated transcription factor genes. THZ531 dramatically induced apoptotic cell death. Small molecules capable of specifically targeting CDK12 and CDK13 may thus help identify cancer subtypes that are particularly dependent on their kinase activities.